Bharat Biotech Slow Downs Covaxin Production, Releases Statement

Hyderabad-based Bharat Biotech, manufactures of India-made Covaxin, announced to slow down production temporarily. On April 1, the pharma company said, "For the coming period, the company will focus on pending facility maintenance, process, and facility optimisation activities". The decision came after recent WHO post Emergency Use Listing inspection, which emphasized on need of optimization activities. The companies also ensured to be working on improved upgrade for Covaxin.